Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-Myeloablative Umbilical Cord Blood Transplant for Advanced Cancers
NCT00365287Phase 2Completed
- Sponsor
- Masonic Cancer Center
- Start
- Jun 2000
- Primary completion
- Dec 2005
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Antibody-Based Therapeutics
01
Overview
Phase 2, open-label trial of cyclophosphamide, fludarabine and antithymocyte globulin rabbit in hematologic cancer, breast cancer and kidney cancer (2 arms), sponsored by Masonic Cancer Center. Primary endpoint: Non-relapse mortality at day 100. Started Jun 2000; status: completed.
02
Drugs
cyclophosphamidefludarabineantithymocyte globulin rabbit
03
Conditions
hematologic cancerbreast cancerkidney cancer
Beyond the preview
Go deeper on NCT00365287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00365287.